Kintara Therapeutics (KTRA) Misses Q2 EPS by 24c
Tweet
Share
E-mailGet Alerts KTRA Hot Sheet
Join SI Premium – FREE
Kintara Therapeutics (NASDAQ: KTRA) reported Q2 EPS of ($0.24).
For earnings history and earnings-related data on Kintara Therapeutics (KTRA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
